Home » Topics » Regulatory » Patents

Patents
RSS

Novel serine/threonine-protein kinase PAK inhibitors designed

Jan. 10, 2012

New MAP kinase p38 inhibitors synthesized

Jan. 10, 2012

Scientists at Merck & Co. prepare new PRCP inhibitors

Jan. 10, 2012

AstraZeneca and Pulmagen Therapeutics patent novel compounds for respiratory disorders

Jan. 10, 2012

Novel estrogen receptor-alpha modulators prepared by Aragon Pharmaceuticals

Jan. 10, 2012

AstraZeneca patents new protein kinase inhibitors

Jan. 10, 2012

New auristatin derivatives for cancer prepared at Bayer Schering Pharma

Jan. 10, 2012

AstraZeneca reports novel dipeptidyl peptidase 1 inhibitors

Jan. 9, 2012

Novel protein-tyrosine kinase inhibitors synthesized in China

Jan. 9, 2012

Novel beta-secretase 1 inhibitors claimed by Janssen Pharmaceutica

Jan. 9, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...